In the last financial year, we received support from GlaxoSmithKline, Merck Sharp & Dohme (UK) Limited, Pfizer and Sanofi, as pharmaceutical companies who share our aim of preventing people from getting meningitis.
Our policy is to receive no more than 25% of our total income from pharmaceutical companies. These sponsors don’t influence the work we provide, but fund specific projects, which are transparently listed in our policy on Funding from pharmaceutical companies (below).
Full disclosure of our income is available in the annual accounts.
Contact us
Would you like to know anything more about this aspect of our work?
Email Carol Currie, our Director of Finance and Administration, or call 0333 405 6273.
Email Carol Email Carol Currie, our Director of Finance and Administration, or call 0333 405 6273.